Results 21 to 30 of about 12,349 (241)
Subcutaneous plasma‐derived human C1‐Inhibitor concentrate (pdC1INH) may be safe and effective for long‐term prophylaxis during pregnancy and lactation in hereditary angioedema patients.
Shimalee Andarawewa +1 more
doaj +1 more source
Hereditary angioedema: approaches to diagnosis and treatment, analysis of a clinical family case
Hereditary angioedema belongs to the group of rare, orphan, genetically determined defects that represent a significant medical and social problem due to the pronounced impact on the quality of life and potential mortality, as well as the emerging ...
O. V. Skorohodkina +3 more
doaj +1 more source
Hereditary angioedema: a disease seldom diagnosed by pediatricians
Objectives: To describe the hereditary angioedema to improve awareness of this condition and reduce diagnostic delay. Data sources: Relevant articles in the MEDLINE database through PubMed.
Régis de Albuquerque Campos +2 more
doaj +1 more source
Angioedema is a non-inflammatory edema of the subcutaneous tissue and/or mucosal membranes. It commonly coexists with urticaria and is considered a deep form of urticaria.
Roman Nowicki +20 more
doaj +1 more source
Outcomes of long term treatments of type I hereditary angioedema in a Turkish family [PDF]
: Background: Hereditary angioedema is a rare autosomal dominantly inherited immunodeficiency disorder characterized by potentially life-threatening angioedema attacks.
Gulsen Akoglu +3 more
doaj +2 more sources
A patient with hereditary angioedema and systemic lupus erythematosus: Coincidence or coexistence?
Angioedema is classified into two major groups: mast cell-mediated (histaminergic) and bradykinin-mediated angioedema. Hereditary angioedema and acquired angioedema are well-defined groups of bradykinin-mediated angioedema. Both hereditary angioedema and
Gokhan Aytekin +3 more
doaj +1 more source
We report an approximately 80% reduction in angioedema attacks with lanadelumab, a mAb targeting plasma kallikrein, in a case of hereditary angioedema with normal C1 inhibitor levels.
Adil Adatia, MD, Bruce Ritchie, MD
doaj +1 more source
C1 inhibitor deficiency: 2014 United Kingdom consensus document [PDF]
C1 inhibitor deficiency is a rare disorder manifesting with recurrent attacks of disabling and potentially life-threatening angioedema. Here we present an updated 2014 United Kingdom consensus document for the management of C1 inhibitor-deficient ...
Ashworth, F +11 more
core +3 more sources
The hereditary angioedema burden of illness study in Europe (HAE-BOIS-Europe) : background and methodology [PDF]
Background: Hereditary angioedema (HAE) is a rare but serious disease marked by swelling attacks in the extremities, face, trunk, airway, or abdominal areas that can be spontaneous or the result of trauma and other triggers.
Aygören-Pürsün, Emel +7 more
core +2 more sources
Risk of angioedema following invasive or surgical procedures in HAE type I and II : the natural history [PDF]
Background: Hereditary angioedema (HAE), caused by deficiency in C1-inhibitor (C1-INH), leads to unpredictable edema of subcutaneous tissues with potentially fatal complications.
Aygören-Pürsün, Emel +4 more
core +1 more source

